News | October 01, 2010

New Proton Therapy Center Opens in Illinois

William Hartsell, M.D., conducts a tour of the new CDH Proton Therapy Center in Warrenville, Ill., for local journalists, including this inclined beam treatment room, one of two in the facility.

October 1, 2010 — A new proton therapy center will open in the suburban Chicago area later this month, slated to begin treating patients November 1. Imaging Technology News editors were among a group of journalists given a pre-opening tour of the ProCure facility, affiliated with Central DuPage Hospital, on September 30.

The CDH Proton Center in Warrenville will have four treatment rooms when it is completed — two inclined beam rooms, one fixed horizontal beam room and one gantry room. The FDA-approved proton therapy equipment was manufactured by IBA of Belgium. The 60,000-square-foot facility, which cost roughly $140 million, will be able to treat approximately 1,500 patients per year at full capacity.

The center is staffed by Radiation Oncology Consultants, a group of 15 board-certified, local physicians. William F. Hartsell, M.D., is president of ROC and medical director of the center. Mark Pankuch, Ph.D., is the center’s director of medical physics and dosimetry. ProCure manages the center, ROC delivers the care and CDH provides all required ancillary services.

To complement the formal presentations about the center and discussion of proton therapy as a treatment for various forms of cancer, the event featured poignant testimonials from three patients who had undergone successful proton therapy treatments at other facilities. As residents of the greater Chicago area, they described the hardships imposed by having to leave their homes and travel great distances to receive treatment in other states, underscoring the benefits of having such a center now available closer to home.

For more information:

Related Content

New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
New U.S. Tariffs on Chinese Goods Include Imaging Equipment
News | Radiology Business | June 15, 2018 | Jeff Zagoudis, Associate Editor
The Office of the U.S. Trade Representative (USTR) released the much-anticipated list of Chinese-manufactured goods...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Overlay Init